Successful Treatment of Autoimmune Disease-Associated Pyoderma Gangrenosum With the IL-1 Receptor Antagonist Anakinra: A Case Series of 3 Patients.
Department of Rheumatology, Princess of Wales Hospital, Bridgend, United Kingdom Celia.Beynon@wales.nhs.uk Department of Dermatology, Princess of Wales Hospital, Bridgend, United Kingdom Department of Dermatology, Neath Port Talbot Hospital, Port Talbot, United Kingdom Department of Rheumatology, Neath Port Talbot Hospital, Port Talbot, United Kingdom Department of Dermatology, Neath Port Talbot Hospital, Port Talbot, United Kingdom Department of Rheumatology, Princess of Wales Hospital, Bridgend, United Kingdom.
Celia
C
Beynon
Mei Fong
MF
Chin
Prasad
P
Hunasehally
Krishnan
K
Bhagwandas
Martin
M
Bevan
Marisa
M
Taylor
Thomas
T
Lawson
D001172:Arthritis, Rheumatoid / Q000150:complications*; D001706:Biopsy / Q000379:methods; D004351:Drug Resistance; D005260:Female; D006801:Humans; D053590:Interleukin 1 Receptor Antagonist Protein / Q000008:administration & dosage*; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D008875:Middle Aged; D017511:Pyoderma Gangrenosum / Q000188:drug therapy / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors; D016896:Treatment Outcome
D053590:Interleukin 1 Receptor Antagonist Protein; D017472:Receptors, Interleukin-1